Parallax | Ep 99: ESC 23 Review: Interventional Trials with Dr Mirvat Alasnag

  • Видео
  • О видео
  • Скачать
  • Поделиться

Parallax | Ep 99: ESC 23 Review: Interventional Trials with Dr Mirvat Alasnag

In this week's Parallax, Dr. Ankur Kalra's guest is Dr. Mirvat Alasnag. Dr. Alasnag is an interventional cardiologist at King Fahad Armed Forces Hospital (KFAFH) in Saudi Arabia. Additionally, she serves as the Editor-in-Chief at Current Cardiovascular Imaging Reports and is a member of the Board of Trustees at SCAI. Dr. Alasnag and Dr. Kalra provide a comprehensive review of the key highlights from ESC Congress 2023. Dr. Alasnag distills the background and latest evidence from key interventional trials, emphasizing their significance for patient care. Tune in to discover the strategies that Dr. Kalra and Dr. Alasnag are currently employing and gain insights into how these data will shape their future decision-making in the catheterization laboratory. Don't miss this informative discussion at the forefront of interventional cardiology. Trials included: -FIRE: Physiology-Guided Complete PCI in Older MI Patients -MULTISTARS AMI: MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction -ILUMIEN IV: Optical coherence tomography-guided coronary stent implantation compared to angiography -OCTOBER: European Trial on Optical Coherence Tomography Optimized -Bifurcation Event Reduction -OCT Vs IVUS Vs Angiography Guidance -OCTIVUS: Optical coherence tomography non-inferior to intravascular ultrasound for stent guidance What are the take-home messages from ESC 2023 for interventional cardiologists? How can we interpret the results for patient care? What new data have the power to change guidelines? Questions and comments can be sent to “podcast@radcliffe-group.com” and may be answered by Ankur in the next episode. Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/?utm_source=youtube&utm_medium=organic_social&utm_term=&utm_campaign=DELV-0000&utm_content=youtube This content is intended for healthcare professionals only. Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster. Like us on Facebook: https://www.facebook.com/RadcliffeCardiology Follow us on Twitter: https://twitter.com/radcliffeCARDIO
350   |   1 год. назад  |   8 - 0
 

Parallax | Ep 99: ESC 23 Review: Interventional Trials with Dr Mirvat Alasnag

Скачайте изображение (превью) выбрав качество


320x180 480x360 640x480 1280x720

In this week's Parallax, Dr. Ankur Kalra's guest is Dr. Mirvat Alasnag. Dr. Alasnag is an interventional cardiologist at King Fahad Armed Forces Hospital (KFAFH) in Saudi Arabia. Additionally, she serves as the Editor-in-Chief at Current Cardiovascular Imaging Reports and is a member of the Board of Trustees at SCAI.
Dr. Alasnag and Dr. Kalra provide a comprehensive review of the key highlights from ESC Congress 2023. Dr. Alasnag distills the background and latest evidence from key interventional trials, emphasizing their significance for patient care.
Tune in to discover the strategies that Dr. Kalra and Dr. Alasnag are currently employing and gain insights into how these data will shape their future decision-making in the catheterization laboratory. Don't miss this informative discussion at the forefront of interventional cardiology.

Trials included:
-FIRE: Physiology-Guided Complete PCI in Older MI Patients
-MULTISTARS AMI: MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction
-ILUMIEN IV: Optical coherence tomography-guided coronary stent implantation compared to angiography
-OCTOBER: European Trial on Optical Coherence Tomography Optimized -Bifurcation Event Reduction
-OCT Vs IVUS Vs Angiography Guidance
-OCTIVUS: Optical coherence tomography non-inferior to intravascular ultrasound for stent guidance

What are the take-home messages from ESC 2023 for interventional cardiologists? How can we interpret the results for patient care? What new data have the power to change guidelines?

Questions and comments can be sent to “podcast@radcliffe-group.com” and may be answered by Ankur in the next episode.

Visit Radcliffe Cardiology:

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Like us on Facebook:
Follow us on Twitter:


Parallax | Ep 99: ESC 23 Review: Interventional Trials with Dr Mirvat Alasnag

Чтобы скачать видео "Parallax | Ep 99: ESC 23 Review: Interventional Trials with Dr Mirvat Alasnag" передвинте ползунок вправо



Покажите вашим друзьям, добавьте в соцсети

Ссылка на страницу с видео:

 

Ссылка HTML на страницу с видео:

 

Код для вставки плеера:


  • Комментарии

Комментарии ФБ


Уважаемые друзья!

Источником всего видеоконтента, в том числе проигрывающегося на страницах ресурса ruslar.me, является сторонний видео ресурс, а именно общедоступный видеохостинг YouTube.com, предоставляющий открытый доступ к своему видеоконтенту (используя открытую и общедоступную технологию video API3 youtube.com)!

Проблемы с авторскими правами

Если вам принадлежат авторские права на данное видео, которое было загружено без вашего согласия на YouTube.com, перейдите на страницу этого видео сайта YouTube.com , нажмите на ссылку под проигрывателем Ещё -> "Пожаловаться" -> "Нарушение моих прав" и в выпадающем меню, выбирите, что именно нарушается и нажмите кнопку "Отправить".



Неприемлемый контент

Чтобы сообщить о неприемлемом видео, перейдите на YouTube, нажмите на ссылку под проигрывателем Ещё -> "Пожаловаться" и выберите в "Сообщить о нарушении" что именно вас не устраивает в этом видео. Подробнее о наших правилах читайте в Условиях использования.